- Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease
- Managing Postoperative Crohn’s Disease Made Easy
- Dispatches from the GUILD Conference 2021
- Teduglutide and Short Bowel Syndrome in Children
- How Common are Pediatric Feeding Disorders?
- Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease
- Managing Postoperative Crohn’s Disease Made Easy
- Dispatches from the GUILD Conference 2021
- Teduglutide and Short Bowel Syndrome in Children
- How Common are Pediatric Feeding Disorders?
- Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease
- Managing Postoperative Crohn’s Disease Made Easy
- Dispatches from the GUILD Conference 2021
- Teduglutide and Short Bowel Syndrome in Children
- How Common are Pediatric Feeding Disorders?
- This event has passed.
The Endoscopy Course: 9th Annual Cases and Controversies in Endoscopy
March 27 - March 28
Gurney’s Newport Resort & Marina, Newport, RI –The Endoscopy Course is designed to take a casebased approach to understand the current role of endoscopy in the care of patients with a variety of gastrointestinal diseases. Numerous challenging topics will be explored, including the basics of endoscopy, innovations in upper and lower GI disorders, gastrointestinal bleeding, and pancreas and biliary tract disorders. In addition, this year’s course will feature lectures on new endoscopic interventions and the application of artificial intelligence to endoscopy. As always, the highlights of this unique educational symposium are the debates between Harvard and Yale faculty on areas of endoscopic controversy.
For more information, visit:
yale.cloud-cme.com/default.aspx?P=0& EID=16122/
or Email: cme@yale.edu